Stephen Albert Johnston, CEO
Stephen Albert Johnston largely focuses on invention. He was inventor/co-inventor of pathogen-derived resistance, mitochondrial transformation, TEV protease system, the gene gun, gene (aka DNA) immunization, expression library immunization, linear expression elements, synbodies, preventative cancer vaccine and immunosignatures. He was professor and director of the Center for Biomedical Inventions at UT-Southwestern Medical Center and professor of Biology and Biomedical Engineering at Duke University before moving to ASU. He has started three companies, Eliance (now Macrogenics), HealthTell and Calviri, the latter two with Neal Woodbury. He is currently Director of the Biodesign Institute Center for Innovations in Medicine and Professor of Life Sciences. He has >150 publications and >20 patents.
Douglas Thamm, Director of Clinical Programs DVM, Ph.D.
Dr. Thamm is also a member of the Developmental Therapeutics Section of the University of Colorado Comprehensive Cancer Center and the Cell and Molecular Biology Graduate Program at Colorado State University. Dr. Thamm received his Bachelors and VMD degrees from the University of Pennsylvania. He completed an Oncology Residency at the University of Wisconsin, and was a researcher there for 5 additional years before joining the faculty at CSU in 2004. He has authored over 115 peer-reviewed publications and 20 book chapters in veterinary and basic cancer research, was Oncology Section Editor for the 2 most recent editions of Kirk’s Current Veterinary Therapy and is Co-Editor-In-Chief of the journal Veterinary and Comparative Oncology. His clinical and research interests include novel targeted therapies for animal and human cancer and ways to integrate these therapies with existing treatment.